Stevens-Johnson Syndrome/Toxic epidermal necrolysis complicated with fulminant type 1 diabetes mellitus: a case report and literature review.

Autor: Zhang X; Department of Endocrinology and Metabolism, Shaoxing People's Hospital, Zhejiang Province, China, 312000., Huang D; Department of Endocrinology and Metabolism, Shaoxing People's Hospital, Zhejiang Province, China, 312000., Lou D; Department of Endocrinology and Metabolism, Shaoxing People's Hospital, Zhejiang Province, China, 312000., Si X; Department of Endocrinology and Metabolism, Shaoxing People's Hospital, Zhejiang Province, China, 312000., Mao J; Department of endocrinology, Peking Union Medical College Hospital, Beijing, China, 100730. maojf@pumch.cn.
Jazyk: angličtina
Zdroj: BMC endocrine disorders [BMC Endocr Disord] 2024 Sep 02; Vol. 24 (1), pp. 172. Date of Electronic Publication: 2024 Sep 02.
DOI: 10.1186/s12902-024-01683-5
Abstrakt: Background: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but life-threatening skin lesion triggered by hypersensitive drug reaction. They are characterized by extensive epidermal necrosis and skin exfoliation. Fulminant type 1 diabetes mellitus (FT1DM) is featured by a rapid-onset of hyperglycemia with ketoacidosis due to severely destroyed β-cell function. Fulminant type 1 diabetes mellitus as a sequela of SJS/TEN has rarely been reported.
Case Presentation: We present a 73-year-old female patient who developed SJS/TEN skin allergic reaction after taking carbamazepine and phenytoin for 35 days. Then, hyperglycemia and diabetic ketoacidosis occurred 20 days after discontinuation of antiepileptic drugs. A very low serum C-peptide level (8.79 pmol/l) and a near-normal glycosylated hemoglobin level met the diagnostic criteria for fulminant T1DM. Intravenous immunoglobulin (IVIG) and insulin were promptly administered, and the patient recovered finally.
Conclusions: This rare case indicates that monitoring blood glucose is necessary in SJS/TEN drug reaction, and comprehensive therapy with rehydration, insulin, antibiotics, and IVIG may improve the prognosis.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje